🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
B-cell Lymphoma is an aggressive and rare cancer of a type of immune cell (...
Status
Active Not Recruiting
Location
The University of Arizona Cancer Center - North Campus /ID# 242219
Start Date
2022-06-14
Trial ID
NCT05283720
This study is an open-label, multicenter, proof of concept, phase 2 trial. ...
Status
Recruiting
Location
Hopital Henri Mondor
Start Date
2024-06-14
Trial ID
NCT06271057
Treatments Being Tested
The purpose of this study is to evaluate the safety, tolerability, drug lev...
Status
Recruiting
Location
Mayo Clinic in Arizona - Phoenix
Start Date
2023-12-29
Trial ID
NCT06090539
Treatments Being Tested
The purpose of this study is to assess the drug levels and safety of golcad...
Status
Completed
Location
Local Institution - 0001
Start Date
2024-08-15
Trial ID
NCT06535399
Treatments Being Tested
This phase I trial tests the safety, side effects and best dose of CC-99282...
Status
Recruiting
Location
Ohio State University Comprehensive Cancer Center
Start Date
2024-01-29
Trial ID
NCT06209619
This phase II trial tests the effectiveness of golcadomide and rituximab as...
Status
Recruiting
Location
Mayo Clinic in Arizona
Start Date
2025-04-02
Trial ID
NCT06834373
The purpose of this study is to evaluate the drug-drug interaction (DDI) po...
Status
Completed
Location
Local Institution - 0002
Start Date
2024-04-23
Trial ID
NCT06363630
Treatments Being Tested
The purpose of this study is to assess the efficacy and safety of golcadomi...
Status
Active Not Recruiting
Location
Local Institution - 0152
Start Date
2024-08-30
Trial ID
NCT06425302
Treatments Being Tested
In this combined phase I/II, open label, single arm trial to study, the saf...
Status
Withdrawn
Location
Multiple Locations
Start Date
2025-06-30
Trial ID
NCT06767956
Treatments Being Tested
Prospective, multicenter, single arm, phase II study, to evaluate the effic...
Status
Recruiting
Location
AOU SS. Antonio e Biagio e Cesare Arrigo di Alessandria - SCDU Ematologia
Start Date
2025-04-09
Trial ID
NCT06835530
Treatments Being Tested